Follow
David S. Kotlyar MD
David S. Kotlyar MD
Clinical Fellow (Oncology), National Cancer Institute, National Institutes of Health
Verified email at nih.gov
Title
Cited by
Cited by
Year
A systematic review of factors that contribute to hepatosplenic T-cell lymphoma in patients with inflammatory bowel disease
DS Kotlyar, MT Osterman, RH Diamond, D Porter, WC Blonski, M Wasik, ...
Clinical Gastroenterology and Hepatology 9 (1), 36-41. e1, 2011
5302011
Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: a meta-analysis
DS Kotlyar, JD Lewis, L Beaugerie, A Tierney, CM Brensinger, JP Gisbert, ...
Clinical Gastroenterology and Hepatology 13 (5), 847-858. e4, 2015
4162015
Non-viral causes of hepatocellular carcinoma
W Blonski, DS Kotlyar, KA Forde
World journal of gastroenterology: WJG 16 (29), 3603, 2010
2582010
Renal function after orthotopic liver transplantation is predicted by duration of pretransplantation creatinine elevation
MS Campbell, DS Kotlyar, CM Brensinger, JD Lewis, K Shetty, RD Bloom, ...
Liver Transplantation 11 (9), 1048-1055, 2005
1972005
A critical review of candidacy for orthotopic liver transplantation in alcoholic liver disease
DS Kotlyar, A Burke, MS Campbell, RM Weinrieb
Official journal of the American College of Gastroenterology| ACG 103 (3 …, 2008
1202008
Recurrence of diseases following orthotopic liver transplantation
DS Kotlyar, MS Campbell, KR Reddy
Official journal of the American College of Gastroenterology| ACG 101 (6 …, 2006
902006
Hepatosplenic T-cell lymphoma in inflammatory bowel disease: a possible thiopurine-induced chromosomal abnormality
DS Kotlyar, W Blonski, RH Diamond, M Wasik, GR Lichtenstein
Official journal of the American College of Gastroenterology| ACG 105 (10 …, 2010
462010
Non-pulmonary allergic diseases and inflammatory bowel disease: a qualitative review
DS Kotlyar, M Shum, J Hsieh, W Blonski, DA Greenwald
World Journal of Gastroenterology: WJG 20 (32), 11023, 2014
382014
Noninvasive monitoring of hepatitis C fibrosis progression
DS Kotlyar, W Blonski, VK Rustgi
Clinics in liver disease 12 (3), 557-571, 2008
142008
S1133 Hepatosplenic T-Cell lymphoma (HSTCL) and inflammatory bowel disease (IBD): a rare complication after long-term thiopurine exposure: case report and systematic review of …
D Kotlyar, W Blonski, DL Porter, M Mendizabal, MV Lin, GR Lichtenstein
Gastroenterology 5 (136), A-196-A-197, 2009
132009
Overall incidence of hepatosplenic T cell lymphoma in patients with inflammatory bowel disease on thiopurines: a meta-analysis of three population based studies
D Kotlyar, JP Gisbert, JD Lewis, CM Brensinger, L Beaugerie, W Blonski, ...
Gastroenterology 5 (140), S-775, 2011
72011
A new meta-analysis of overall risk of lymphoma in patients with inflammatory bowel disease on thiopurine therapy; inclusion of the Eneida Population Study from Spain, and …
D Kotlyar, JP Gisbert, JD Lewis, CM Brensinger, L Beaugerie, W Blonski, ...
Gastroenterology 5 (140), S-42, 2011
52011
958 Case report of trisomy 13 in bone marrow in a case of hepatosplenic T-cell lymphoma (HSTCL) and inflammatory bowel disease (IBD)
D Kotlyar, W Blonski, M Mendizabal, MV Lin, GR Lichtenstein
Gastroenterology 136 (5), A-146, 2009
42009
Demographic Difference of Hepatosplenic T-Cell Lymphoma (HSTCL) Versus Non-HSTCL Lymphoma in Patients with IBD Receiving Thiopurines: A Population Cohort Analysis: 1568
D Kotlyar, J Gisbert, M Chaparro, E Loftus, W Blonski, G Lichtenstein
Official journal of the American College of Gastroenterology| ACG 107, S632, 2012
32012
T1287 Risk of Postoperative Infections in IBD Patients Treated With Perioperative Anti-TNF Therapy: A Meta-Analysis
W Blonski, MT Osterman, MV Lin, CM Brensinger, D Kotlyar, I Sonu, ...
Gastroenterology 138 (5), S-529, 2010
32010
Sa1232 Systematic Review: Duration of Exposure to Azathioprine/6-MP as a Risk Factor for Lymphoma
D Kotlyar, JP Gisbert, M Chaparro, EV Loftus, W Blonski, GR Lichtenstein
Gastroenterology 5 (142), S-250, 2012
22012
Systematic Review: Comparison of Chromosomal Abnormalities in Patients With Hepatosplenic T-Cell Lymphoma–IBD-Related Versus Non-IBD Related Cases
D Kotlyar, R Hirten, SM Horwitz, W Blonski, GR Lichtenstein
Gastroenterology 5 (140), S-769-S-770, 2011
22011
W1130 The Use of Immunosuppressive Medications As Risk Factor for Non-Opportunistic Infectious Complications in Patients with IBD
MV Lin, MF Pascua, F Aberra, W Blonski, D Kotlyar, MT Osterman, ...
Gastroenterology 5 (136), A-660, 2009
22009
Su1147 Meta-Analysis of Overall Risk of Lymphoma in Patients With Inflammatory Bowel Disease on Thiopurine Therapy With Inclusion of European and North American Studies …
D Kotlyar, JD Lewis, L Beaugerie, A Tierney, CM Brensinger, EV Loftus, ...
Gastroenterology 5 (144), S-411, 2013
12013
Meta-analysis of the Incidence of Hepatosplenic T-cell Lymphoma in Inflammatory Bowel Disease: An Update: 1257
D Kotlyar, L Beaugerie, J Lewis, J Gisbert, C Brensinger, W Blonski, ...
Official journal of the American College of Gastroenterology| ACG 106, S477-S478, 2011
12011
The system can't perform the operation now. Try again later.
Articles 1–20